IGF-1R signaling diminishes chemotherapeutic responses in BC through various mechanisms, including promoting proliferation, enhancing cancer stemness, and inhibiting apoptosis via DNA damage repair [13]. This evidence concerns the gene IGF1R and breast cancer.